Table 3.
Men (n = 6216) | Women (n = 4847) | |||
---|---|---|---|---|
Model 1 | Model 2 | Model 1 | Model 2 | |
Diagnosis | ||||
Hypertension | 0.98 (0.78–1.24) | 0.95 (0.75–1.21) | 0.78 (0.63–0.96) | 0.77 (0.62–0.95) |
Myocardial infarction | 0.87 (0.61–1.24) | 0.92 (0.64–1.33) | 0.51 (0.34–0.77) | 0.52 (0.35–0.79) |
Congestive heart failure | 0.71 (0.55–0.90) | 0.71 (0.56–0.91) | 0.65 (0.53–0.81) | 0.68 (0.55–0.85) |
Cerebrovascular diseases | 1.02 (0.77–1.36) | 0.98 (0.73–1.31) | 0.75 (0.57–0.98) | 0.69 (0.52–0.91) |
Ischemic stroke | 1.08 (0.81–1.45) | – | 0.75 (0.57–0.99) | – |
Bleeding stroke | 0.60 (0.22–1.62) | – | 0.75 (0.28–2.02) | – |
Obesity | 0.58 (0.24–1.43) | 0.54 (0.22–1.32) | 0.64 (0.30–1.35) | 0.62 (0.29–1.34) |
Diabetes mellitus | 1.40 (1.08–1.83) | 1.50 (1.15–1.96) | 1.07 (0.83–1.39) | 1.20 (0.92–1.56) |
COPD | 0.77 (0.52–1.15) | 0.80 (0.54–1.20) | 1.24 (0.93–1.67) | 1.28 (0.95–1.72) |
Depression | 1.67 (1.14–2.44) | 1.54 (1.04–2.28) | 1.18 (0.87–1.61) | 1.16 (0.85–1.59) |
Anxiety | 1.56 (0.87–2.78) | 1.46 (0.80–2.65) | 1.24 (0.82–1.88) | 1.23 (0.80–1.88) |
Anticoagulant treatment | – | 0.78 (0.61–0.98) | – | 0.81 (0.65–0.99) |
Model 1 is for each comorbidity separately and adjusted for age and sociodemographic variables (educational level, marital status, and neighborhood socioeconomic status). Model 2 is multivariate with adjustment as in model 1 but also for all comorbidities (hypertension, myocardial infarction, congestive heart failure, cerebrovascular diseases, obesity, diabetes, COPD, depression, and anxiety) and anticoagulant treatment. Significant interaction was found between age and marital status. Italicized values are statistically significant